1. Home
  2. MXCT vs TEAF Comparison

MXCT vs TEAF Comparison

Compare MXCT & TEAF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MXCT
  • TEAF
  • Stock Information
  • Founded
  • MXCT 1999
  • TEAF 2017
  • Country
  • MXCT United States
  • TEAF United States
  • Employees
  • MXCT N/A
  • TEAF N/A
  • Industry
  • MXCT Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • TEAF Trusts Except Educational Religious and Charitable
  • Sector
  • MXCT Health Care
  • TEAF Finance
  • Exchange
  • MXCT Nasdaq
  • TEAF Nasdaq
  • Market Cap
  • MXCT 159.9M
  • TEAF 167.4M
  • IPO Year
  • MXCT 2021
  • TEAF N/A
  • Fundamental
  • Price
  • MXCT $1.67
  • TEAF $12.39
  • Analyst Decision
  • MXCT Buy
  • TEAF
  • Analyst Count
  • MXCT 4
  • TEAF 0
  • Target Price
  • MXCT $7.50
  • TEAF N/A
  • AVG Volume (30 Days)
  • MXCT 561.6K
  • TEAF 56.1K
  • Earning Date
  • MXCT 11-12-2025
  • TEAF 01-01-0001
  • Dividend Yield
  • MXCT N/A
  • TEAF 9.20%
  • EPS Growth
  • MXCT N/A
  • TEAF N/A
  • EPS
  • MXCT N/A
  • TEAF N/A
  • Revenue
  • MXCT $35,754,000.00
  • TEAF N/A
  • Revenue This Year
  • MXCT N/A
  • TEAF N/A
  • Revenue Next Year
  • MXCT $14.72
  • TEAF N/A
  • P/E Ratio
  • MXCT N/A
  • TEAF N/A
  • Revenue Growth
  • MXCT N/A
  • TEAF N/A
  • 52 Week Low
  • MXCT $1.26
  • TEAF $11.11
  • 52 Week High
  • MXCT $5.20
  • TEAF $13.30
  • Technical
  • Relative Strength Index (RSI)
  • MXCT 54.49
  • TEAF 67.34
  • Support Level
  • MXCT $1.45
  • TEAF $12.30
  • Resistance Level
  • MXCT $1.57
  • TEAF $12.60
  • Average True Range (ATR)
  • MXCT 0.11
  • TEAF 0.12
  • MACD
  • MXCT -0.00
  • TEAF 0.05
  • Stochastic Oscillator
  • MXCT 71.40
  • TEAF 76.40

About MXCT MaxCyte Inc.

MaxCyte Inc is a commercial cell engineering company focused on providing enabling platform technologies to advance the discovery, development and commercialization of next-generation cell therapeutics and to support cell-based research and development. The company has developed and commercialized a proprietary Flow Electroporation platform, which facilitates the complex engineering of a wide variety of cells. The Company has one reportable segment, cell engineering technology. The revenue is generated from the sale and licensing of company's instruments, as well as sales of single-use disposable processing assemblies.

About TEAF Ecofin Sustainable and Social Impact Term Fund

Tortoise Sustainable and Social Impact Term Fund Formerly Tortoise Essential Assets Income Term is a USA-based non-diversified, closed-end management investment company. Its investment objective is to provide common shareholders with a high level of total return with an emphasis on current distributions.

Share on Social Networks: